Ataluren

Results: 8



#Item
11  ANN Newsletter - No. 5 / October 2011 C li ni ca l T r i al s: UPD ATE Exon Skipping

1 ANN Newsletter - No. 5 / October 2011 C li ni ca l T r i al s: UPD ATE Exon Skipping

Add to Reading List

Source URL: www.ann.org.au

Language: English - Date: 2011-10-13 05:16:20
2September 17, 2014  PTC Therapeutics Expands Global Presence in Support of Translarna™ Launch in Duchenne Muscular Dystrophy SOUTH PLAINFIELD, N.J., Sept. 17, 2014 /PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT)

September 17, 2014 PTC Therapeutics Expands Global Presence in Support of Translarna™ Launch in Duchenne Muscular Dystrophy SOUTH PLAINFIELD, N.J., Sept. 17, 2014 /PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT)

Add to Reading List

Source URL: hbmpartners.com

Language: English - Date: 2014-09-18 03:00:04
3Phase 3 Study of Ataluren in Patients with Nonsense Mutation Duchenne Muscular Dystrophy: Frequently Asked Questions What is ataluren? Ataluren (formerly called PTC124®) is an investigational new drug, which means it is

Phase 3 Study of Ataluren in Patients with Nonsense Mutation Duchenne Muscular Dystrophy: Frequently Asked Questions What is ataluren? Ataluren (formerly called PTC124®) is an investigational new drug, which means it is

Add to Reading List

Source URL: muscle.ca

Language: English - Date: 2013-11-30 21:08:11
4PTC Therapeutics Raises $26.6 Million In Private Placement Financing Company Developing Small-Molecule Drugs Targeting Post-Transcriptional Control Mechanisms Has Raised Over $130 Million To Date SOUTH PLAINFIELD, NJ - N

PTC Therapeutics Raises $26.6 Million In Private Placement Financing Company Developing Small-Molecule Drugs Targeting Post-Transcriptional Control Mechanisms Has Raised Over $130 Million To Date SOUTH PLAINFIELD, NJ - N

Add to Reading List

Source URL: capital.vulcan.com

Language: English - Date: 2008-09-12 20:32:06
5Dr. Jack Parent, MD  Dr. Lori Isom, PhD Dr. Miriam Meisler, PhD

Dr. Jack Parent, MD Dr. Lori Isom, PhD Dr. Miriam Meisler, PhD

Add to Reading List

Source URL: www.dravetfoundation.org

Language: English - Date: 2013-12-03 16:27:27
6Microsoft PowerPoint - TsengCMDcopy

Microsoft PowerPoint - TsengCMDcopy

Add to Reading List

Source URL: www.curecmd.org

Language: English - Date: 2010-09-09 13:12:18
7COMMUNIQUE DE PRESSE Vendredi 23 mai 2014 AMM conditionnelle pour l’Ataluren Une première pour un médicament de thérapie innovante pour la myopathie de Duchenne

COMMUNIQUE DE PRESSE Vendredi 23 mai 2014 AMM conditionnelle pour l’Ataluren Une première pour un médicament de thérapie innovante pour la myopathie de Duchenne

Add to Reading List

Source URL: www.myologie.org

Language: French - Date: 2014-05-28 01:46:52
    8COMMUNIQUE DE PRESSE Vendredi 23 mai 2014 AMM conditionnelle pour l’Ataluren Une première pour un médicament de thérapie innovante pour la myopathie de Duchenne

    COMMUNIQUE DE PRESSE Vendredi 23 mai 2014 AMM conditionnelle pour l’Ataluren Une première pour un médicament de thérapie innovante pour la myopathie de Duchenne

    Add to Reading List

    Source URL: www.institut-myologie.org

    Language: French - Date: 2014-05-28 01:46:52